SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-19-004539
Filing Date
2019-03-07
Accepted
2019-03-07 16:27:58
Documents
91
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1646033
2 EXHIBIT 10.7 ex10_7.htm EX-10.7 73964
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2775
4 EXHIBIT 24.1 ex24_1.htm EX-24.1 17211
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 14361
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 7886
  Complete submission text file 0001140361-19-004539.txt   7645738

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rnn-20181231.xml EX-101.INS 1808662
8 XBRL TAXONOMY EXTENSION SCHEMA rnn-20181231.xsd EX-101.SCH 62028
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20181231_cal.xml EX-101.CAL 45984
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20181231_def.xml EX-101.DEF 192355
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20181231_lab.xml EX-101.LAB 427835
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20181231_pre.xml EX-101.PRE 388109
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 19666187
SIC: 2834 Pharmaceutical Preparations